Phase II trial of sorafenib in patients with metastatic breast cancer previously exposed to anthracyclines or taxanes: North Central Cancer Treatment Group and Mayo Clinic Trial N0336.
暂无分享,去创建一个
E. Perez | K. Rowland | W. Lingle | P. Flynn | R. Morton | T. Fitch | A. Moreno-Aspitia | D. Hillman | M. Wiesenfeld